Key Appointment At MSD China Shows Long-Term Investment
This article was originally published in PharmAsia News
Executive Summary
Merck, Sharpe & Dohme recently appointed health care veteran Michel Vounatsos as MSD China president. Before coming to China, he was president of MSD France, one of the firm's most important markets outside the U.S. The current appointment shows the company's long-term investment and commitment in China as well as the country's strategic importance for MSD. Vounatsos said China is a key market for MSD; the firm will continue to provide innovative drugs and services for Chinese customers as well as offer full support to the nation's health care reform. (Click here for more - Chinese language)
You may also be interested in...
Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.